Novartis Ag (NVS) Net Cash Flow (QoQ) (2009 - 2025)

Novartis Ag (NVS) Net Cash Flow (QoQ) (2009 - 2025) Analysis & Trends

Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Gsk 93,699,046.73 Bn 93,699,041.77 Bn 7.76 Bn
2 Eli Lilly 1,012.06 Bn 1,006.77 Bn 16.22 Bn
3 Johnson & Johnson 560.67 Bn 538.62 Bn 15.96 Bn
4 AbbVie 402.20 Bn 392.85 Bn 10.78 Bn
5 Merck 298.59 Bn 292.94 Bn 12.09 Bn
6 Amgen 188.77 Bn 176.74 Bn 5.87 Bn
7 Gilead Sciences 160.22 Bn 152.49 Bn 5.52 Bn
8 Pfizer 148.19 Bn 135.42 Bn -1.21 Bn
9 Bristol Myers Squibb 116.72 Bn 106.26 Bn 8.07 Bn
10 Novartis Ag 109.78 Bn 109.09 Bn -

Historic Data

Download Data
DateValue
Dec 31, 2025 -144.65%
Sep 30, 2025 -8.59%
Jun 30, 2025 -340.00%
Mar 31, 2025 106.19%
Dec 31, 2024 -605.03%
Sep 30, 2024 50.65%
Jun 30, 2024 -70.41%
Mar 31, 2024 -105.70%
Dec 31, 2023 1,996.88%
Sep 30, 2023 27.65%
Jun 30, 2023 -584.52%
Mar 31, 2023 98.07%
Dec 31, 2021 -248.95%
Sep 30, 2021 -195.67%
Jun 30, 2021 64.84%
Mar 31, 2021 -83.55%
Dec 31, 2018 236.38%
Sep 30, 2018 -109.97%
Dec 31, 2017 -52.40%
Sep 30, 2017 -336.26%